Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Devrim DundarGulden Sonmez Tamer

Abstract

The aims of this study were to determine the susceptibilities to macrolide and tetracycline antibiotics and emm type distribution of Streptococcus pyogenes strains isolated in the Kocaeli University Hospital, Turkey. A total of 127 S. pyogenes clinical isolates were tested. Eleven (9%) isolates were resistant to erythromycin, and 23 (18%) isolates were resistant to tetracycline. Ten of the erythromycin-resistant isolates were also resistant to tetracycline. By the triple-disk test, all erythromycin-resistant isolates showed the inducible macrolide-lincosamide-streptogramin-C phenotype and harbored erm(TR) gene. tet(O) was the most common tetracycline resistance gene. Among erythromycin-tetracycline coresistant isolates, seven harbored the tet(O) gene. emm 4, emm 1, emm 2,114, and emm 89 were the most common emm types. These isolates were more susceptible to erythromycin. There was considerable emm type heterogeneity in macrolide or tetracycline resistant isolates. According to our knowledge, this is the first study in which emm type distribution is investigated in Turkey. More comprehensive studies are needed to obtain true information about the epidemiology of macrolide and tetracycline resistance and emm type distribution in ...Continue Reading

References

Jul 1, 1991·Antimicrobial Agents and Chemotherapy·R Leclercq, P Courvalin
Apr 1, 1996·Journal of Clinical Microbiology·B BeallT Thompson
Oct 6, 2000·The Journal of Antimicrobial Chemotherapy·M ArvandJ Wagner
May 31, 2001·Microbiology and Molecular Biology Reviews : MMBR·I Chopra, M Roberts
Oct 2, 2002·Journal of Clinical Microbiology·Antoaneta DetchevaBernard Beall
Nov 30, 2002·International Journal of Antimicrobial Agents·Filiz AkataMurat Tugrul
Jun 14, 2003·The Journal of Antimicrobial Chemotherapy·Ziya Cibali AcikgozSerdar Tuncer
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stanford T ShulmanUNKNOWN US Streptococcal Pharyngitis Surveillance Group
Aug 25, 2004·International Journal of Antimicrobial Agents·Rainer GattringerApostolos Georgopoulos
Aug 26, 2004·Antimicrobial Agents and Chemotherapy·Edouard BingenRobert Cohen
Sep 24, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Hans Ulrik K NielsenNiels Frimodt-Møller
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert R TanzUNKNOWN North American Streptococcal Pharyngitis Surveillance Group
Apr 28, 2005·Antimicrobial Agents and Chemotherapy·C Silva-CostaUNKNOWN Portuguese Surveillance Group for the Study of Respiratory Pathogens
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sandra S RichterGary V Doern
Apr 28, 2006·Antimicrobial Agents and Chemotherapy·P LittauerG S Simonsen
Jun 27, 2006·Scandinavian Journal of Infectious Diseases·Sule ColakogluGulsen Hascelik
Sep 27, 2006·International Journal of Antimicrobial Agents·Milagrosa MontesEmilio Pérez-Trallero
Jan 31, 2007·Antimicrobial Agents and Chemotherapy·Andrea BrencianiEleonora Giovanetti
Feb 20, 2007·Antimicrobial Agents and Chemotherapy·Vanessa AyerDebra E Bessen
Mar 24, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M KoliouE S Soteriades
Aug 30, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A StathiP T Tassios
Nov 13, 2008·Antimicrobial Agents and Chemotherapy·Pietro E VaraldoEleonora Giovanetti
Dec 3, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C Silva-CostaUNKNOWN Portuguese Surveillance Group for the Study of Respiratory Pathogens
Apr 28, 2009·Diagnostic Microbiology and Infectious Disease·Athanasios G MichosVassiliki P Syriopoulou
Sep 26, 2009·The Lancet Infectious Diseases·Andrew C SteerJonathan R Carapetis

❮ Previous
Next ❯

Citations

Oct 12, 2011·Antimicrobial Agents and Chemotherapy·Eleonora GiovanettiPietro Emanuele Varaldo
Oct 3, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Bibiana ChazanRaul Colodner
Apr 7, 2016·The Journal of Antimicrobial Chemotherapy·G SoyletirD Torumkuney
Oct 10, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H Erdem, M Akova
Dec 20, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sonia KsiaAmel Kechrid
Nov 15, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Chuanling ZhangQingzhong Liu
Nov 18, 2017·Emerging Infectious Diseases·Ana Isabel VelaJosé Francisco Fernández-Garayzábal
Mar 19, 2011·Current Opinion in Infectious Diseases·Nicola N LynskeyShiranee Sriskandan

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

Epi Info ( TM )
Vector NTI

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
V MijacN Opavski
© 2021 Meta ULC. All rights reserved